Singapore-Based Innovative Biomedical Start-Up Achieves “Strategic Triumph“ to Conquer Chinese Med-Tech Market
Hanover/Beijing/Singapore (ots) - ● NMPA grants Syntellix product approval for the world's most important future market with more than 1.4 billion people ● Syntellix‘ product approval for China is the largest and most important success in the company’s history; product approval in China was the company’s ...